Patents by Inventor Minnie Wu

Minnie Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7968596
    Abstract: The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.
    Type: Grant
    Filed: August 24, 2006
    Date of Patent: June 28, 2011
    Assignee: Australian Biomedical Company Pty, Ltd.
    Inventors: Peter James Jenkins, Minnie Wu, David Shine Wu
  • Patent number: 7435756
    Abstract: The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like.
    Type: Grant
    Filed: February 12, 2004
    Date of Patent: October 14, 2008
    Assignee: Australian Biomedical Company Pty, Ltd.
    Inventors: Peter James Jenkins, Minnie Wu, David Shine Wu
  • Publication number: 20070197456
    Abstract: The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.
    Type: Application
    Filed: August 24, 2006
    Publication date: August 23, 2007
    Applicant: AUSTRALIAN BIOMEDICAL COMPANY PTY, LTD
    Inventors: Peter Jenkins, Minnie Wu, David Wu
  • Publication number: 20050215496
    Abstract: The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.
    Type: Application
    Filed: May 20, 2005
    Publication date: September 29, 2005
    Inventors: Peter Jenkins, Minnie Wu, David Wu
  • Publication number: 20040162248
    Abstract: The present invention relates to application of compounds of formula (1) (Gibberellins) and their derivatives for the preparation of a pharmaceutical composition or medicaments for the treatment of diabetes, its complications and associated conditions, including obesity, micro and macro vascular diseases, nephropathy, neuropathy, eye diseases, diabetic ulcerations and the like. The method results the normalization of serum glucose level and other physiological conditions.
    Type: Application
    Filed: February 12, 2004
    Publication date: August 19, 2004
    Inventors: Peter James Jenkins, Minnie Wu, David Shine Wu